Microbot Medical Inc
MBOT
View Detailed Chart
2.305USD
-0.315-12.02%
Market hours （ET）Quotes delayed by 15 min
33.36KMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-12.02%
5 Days
-9.25%
1 Month
-4.36%
6 Months
-27.97%
Year to Date
+15.25%
1 Year
+57.88%
View Detailed Chart
TradingKey Stock Score of Microbot Medical Inc
Currency: USD Updated: 2026-03-27Key Insights
Microbot Medical Inc's fundamentals are relatively weak, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 141 out of 391 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 7.50.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Microbot Medical Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Microbot Medical Inc Highlights
StrengthsRisks
Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 0.00.
Undervalued
The company’s latest PE is -8.33, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 10.98M shares, increasing 29.88% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 3.33M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.02.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
7.500
Target Price
+186.26%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Microbot Medical Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Microbot Medical Inc Info
Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
Ticker SymbolMBOT
CompanyMicrobot Medical Inc
CEOGadot (Harel)
Websitehttp://www.microbotmedical.com/
Related Instruments
+1.15%
-0.28%
+0.80%
+5.91%
-0.71%
+1.76%
+1.67%
+0.33%
-0.27%
+0.34%
-2.84%
+0.47%
+0.70%
+2.44%
-2.78%
0.00%
+0.23%
+1.88%
-0.54%
+1.93%Popular Symbols
246.419
-2.381 (-0.96%)
165.440
-2.080 (-1.24%)
66626.200
+42.150 (+0.06%)
252.125
-21.225 (-7.76%)
2028.910
+28.910 (+1.45%)
355.640
-6.190 (-1.71%)
4500.360
+7.840 (+0.18%)
102.452
+1.843 (+1.83%)
1.146
-0.004 (-0.39%)
159.623
-0.629 (-0.39%)
